Cardiol Therapeutics (CRDL) Receivables (2020 - 2026)
Cardiol Therapeutics' Receivables came in at $225,994 for Q2 2026, up 11.9% from $201,998 a year earlier but down 8.8% from the prior quarter.
Analysis
Cardiol Therapeutics (CRDL) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2025, Cardiol Therapeutics' Receivables was $161,893, down 38.7% from FY2024.
- Receivables carries a five-year compound annual growth rate of -21.1% (FY2020 to FY2025).
- Going back by year, Receivables was $264,128 in FY2024 (+28.5%), $205,576 in FY2023 (-41.9%), $353,763 in FY2022 (+8.9%) and $324,869 in FY2021 (-38.5%).
- The five-year range for quarterly Receivables is -$48,805 (Q4 2021) to $383,686 (Q1 2022).
- Year-over-year, Receivables increased in five of the last eight quarters, with an average decline of 3.7%.
- The fastest year-over-year change in Receivables over five years came in Q4 2024 (growth of 25.9%), and the weakest in Q2 2022 (a decline of 43.1%).
- Business Quant data shows CRDL's Receivables at $247,716 (Q1 2026), $162,201 (Q4 2025) and $142,333 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Cardiol Therapeutics | 102.21 Mn | 40.00 Mn | - | 220,009.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 220,009.14 |
| Mar 31, 2026 | 243,896.23 |
| Dec 31, 2025 | 165,169.73 |
| Sep 30, 2025 | 140,756.81 |
| Jun 30, 2025 | 204,574.83 |
| Mar 31, 2025 | 242,286.39 |
| Dec 31, 2024 | 252,004.19 |
| Sep 30, 2024 | 197,431.31 |
| Jun 30, 2024 | 176,960.87 |
| Mar 31, 2024 | 234,268.61 |
| Dec 31, 2023 | 211,549.85 |
| Sep 30, 2023 | 214,657.92 |
| Jun 30, 2023 | 230,240.74 |
| Mar 31, 2023 | 301,853.30 |
| Dec 31, 2022 | 354,336.60 |
| Sep 30, 2022 | 330,597.08 |
| Jun 30, 2022 | 313,291.64 |
| Mar 31, 2022 | 389,352.12 |
| Dec 31, 2021 | 319,455.58 |
| Sep 30, 2021 | 302,163.27 |
API Access
Cardiol Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CRDL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CRDL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CRDL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();